GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetics Generation Advancement Corp (ROCO:4160) » Definitions » Shiller PE Ratio

Genetics Generation Advancement (ROCO:4160) Shiller PE Ratio : 230.65 (As of Mar. 04, 2025)


View and export this data going back to 2012. Start your Free Trial

What is Genetics Generation Advancement Shiller PE Ratio?

As of today (2025-03-04), Genetics Generation Advancement's current share price is NT$71.50. Genetics Generation Advancement's E10 for the quarter that ended in Sep. 2024 was NT$0.31. Genetics Generation Advancement's Shiller PE Ratio for today is 230.65.

The historical rank and industry rank for Genetics Generation Advancement's Shiller PE Ratio or its related term are showing as below:

ROCO:4160' s Shiller PE Ratio Range Over the Past 10 Years
Min: 217.1   Med: 523.51   Max: 2006
Current: 227.54

During the past years, Genetics Generation Advancement's highest Shiller PE Ratio was 2006.00. The lowest was 217.10. And the median was 523.51.

ROCO:4160's Shiller PE Ratio is ranked worse than
97.3% of 74 companies
in the Medical Diagnostics & Research industry
Industry Median: 26.83 vs ROCO:4160: 227.54

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Genetics Generation Advancement's adjusted earnings per share data for the three months ended in Sep. 2024 was NT$0.720. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is NT$0.31 for the trailing ten years ended in Sep. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Genetics Generation Advancement Shiller PE Ratio Historical Data

The historical data trend for Genetics Generation Advancement's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetics Generation Advancement Shiller PE Ratio Chart

Genetics Generation Advancement Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 531.74

Genetics Generation Advancement Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,307.86 531.74 341.48 562.25 294.52

Competitive Comparison of Genetics Generation Advancement's Shiller PE Ratio

For the Diagnostics & Research subindustry, Genetics Generation Advancement's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genetics Generation Advancement's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetics Generation Advancement's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Genetics Generation Advancement's Shiller PE Ratio falls into.



Genetics Generation Advancement Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Genetics Generation Advancement's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=71.50/0.31
=230.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genetics Generation Advancement's E10 for the quarter that ended in Sep. 2024 is calculated as:

For example, Genetics Generation Advancement's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.72/133.0289*133.0289
=0.720

Current CPI (Sep. 2024) = 133.0289.

Genetics Generation Advancement Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201412 -1.226 99.070 -1.646
201503 -0.145 99.621 -0.194
201506 0.136 100.684 0.180
201509 -0.118 100.392 -0.156
201512 -0.363 99.792 -0.484
201603 -0.004 100.470 -0.005
201606 -0.136 101.688 -0.178
201609 0.073 101.861 0.095
201612 -0.254 101.863 -0.332
201703 0.245 102.862 0.317
201706 0.018 103.349 0.023
201709 0.136 104.136 0.174
201712 0.009 104.011 0.012
201803 0.372 105.290 0.470
201806 0.109 106.317 0.136
201809 0.036 106.507 0.045
201812 0.109 105.998 0.137
201903 0.336 107.251 0.417
201906 0.300 108.070 0.369
201909 -0.002 108.329 -0.002
201912 0.045 108.420 0.055
202003 0.009 108.902 0.011
202006 -0.091 108.767 -0.111
202009 -0.173 109.815 -0.210
202012 -0.345 109.897 -0.418
202103 -0.018 111.754 -0.021
202106 0.236 114.631 0.274
202109 0.136 115.734 0.156
202112 -0.064 117.630 -0.072
202203 0.400 121.301 0.439
202206 0.036 125.017 0.038
202209 0.295 125.227 0.313
202212 0.238 125.222 0.253
202303 0.276 127.348 0.288
202306 0.352 128.729 0.364
202309 0.180 129.860 0.184
202312 0.256 129.419 0.263
202403 0.533 131.776 0.538
202406 0.676 132.554 0.678
202409 0.720 133.029 0.720

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Genetics Generation Advancement  (ROCO:4160) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Genetics Generation Advancement Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Genetics Generation Advancement's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Genetics Generation Advancement Business Description

Traded in Other Exchanges
N/A
Address
No. 28, Lane 36, Xinhu 1st Road, 6th Floor, Neihu District, Taipei, TWN, 11494
Genetics Generation Advancement Corp is a Taiwan based company specialized in genetic testing and scientific information. It is engaged in providing services for the detection of genetic defects and prevention in newborns. Their main services include amniotic fluid chromosome chip screening, pre-implantation genetic diagnosis, and Molecular DNA testing diagnostics. The company is focused on the majority of areas of maternal precision medicine, pediatric disease diagnosis, drug-associated diagnosis, non-invasive cancer detection, and precise health management. The business units of the company are the Genetic Testing Unit and Informatics business unit.

Genetics Generation Advancement Headlines

No Headlines